Has Antoni Goral, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,983 in general payments to Antoni Goral, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Antoni Goral, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Antoni Goral, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Antoni Goral, MD

Adult Reconstructive Orthopaedic Surgery · Chevy Chase, MDNPI 1013915487

Payments from drug & device makers

What this record shows

This record is dominated by education: $1,513 of the $1,983 with a category attached, or 76.3%. Zimmer Biomet accounts for 82.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $1,293 and has fallen 95.8% since, to $54 in 2024. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in MD, where the typical reported total is $10,251.

$1,983in general payments, 2019–2025

Across 20 payments — averaging $99.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$2K
Stryker$243
Biocomposites Inc$47
Pacira Therapeutics, Inc.$40
Amgen$11

What the payments were for

Food & beverage$47024%
Education$1,51376%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	11	$1,641
Stryker	5	$243
Biocomposites Inc	1	$47
Pacira Therapeutics, Inc.	2	$40
Amgen	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,983 in reported general payments places this provider in the 20th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.

See all adult reconstructive orthopaedic surgery providers in Maryland →

Medicare billing

Part B allowed, 2024

$314,401

Medicare patients

515

Services billed

6,048

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	52	$18,875
Diclofenac Potassium	24	$569
Oxycodone Hcl	101	$338
Celecoxib	30	$333
Tramadol Hcl	93	$208
Meloxicam	30	$176
Amoxicillin	64	$126
Methylprednisolone	16	$97

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Chevy Chase

Randal LewisChevy Chase$2.6M
Ryan ScullyChevy Chase$43K
Michael MontBaltimore$10.9M
Sridhar DurbhakulaBethesda$766K
Pasquale PetreraSalisbury$137K
Pablo WagnerBaltimore$118K
James NaceBaltimore$102K
John SteeleTowson$52K
David SilberWestminster$37K
Mark HasenauerBaltimore$35K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →